Products for Research Use Only

TREM2-IN-1

CAT: 0804-HY-160421-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-160421-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TREM2-IN-1 (OPA) is a TREM2 inhibitor derived from oxaliplatin and artesunate. TREM2-IN-1 can relieves immunosuppressive tumor microenvironment and enhancing chemical anticancer efficiency. TREM2-IN-1 deters the tumor growth in mice models bearing MC38 colorectal tumor by reducing the number of CD206+ and CX3CR1+ immunosuppressive macrophages. TREM2-IN-1 also promotes the expansion and infiltration of immunostimulatory dendritic, cytotoxic T and natural killer cells[1].
CAS Number
2000236-36-0
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/trem2-in-1.html
Concentration
10mM
Purity
99.34
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O[C@@H]1[C@H](C)[C@@](CC[C@@H](C)[C@]2([H])CC[C@](OO3)(C)O4)([H])[C@@]23[C@]4([H])O1)CCC(O[Pt]5(OC6=O)(OC6=O)(OC(CCC(O[C@@H]7[C@H](C)[C@@](CC[C@@H](C)[C@]8([H])CC[C@]9(C)O%10)([H])[C@@]8(OO9)[C@]%10([H])O7)=O)=O)[NH2][C@H](CCCC%11)[C@@H]%11[NH2]5)=O
Molecular Formula
C46H68N2O20Pt
Molecular Weight
1164.12
References & Citations
[1]Yang T, et al. Platinum-Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment. Angew Chem Int Ed Engl. 2023 Jan 9;62 (2) :e202213337.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Chemical Information

cyclohexane-1,2-diamine;oxalate;bis(4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoate);platinum(4+)
CAS Number2000236-36-0
PubChem CID176419014
IUPAC Namecyclohexane-1,2-diamine;oxalate;bis(4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoate);platinum(4+)
Molecular FormulaC46H68N2O20Pt
Molecular Weight1164.1
Topological Polar Surface Area339
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count22
Rotatable Bond Count12
Heavy Atom Count69
Formal Charge0
Complexity1720
SMILES
C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)[O-])C.C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)[O-])C.C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+4]
InChI
InChI=1S/2C19H28O8.C6H14N2.C2H2O4.Pt/c2*1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19;7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h2*10-13,16-17H,4-9H2,1-3H3,(H,20,21);5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;;;+4/p-4/t2*10-,11-,12+,13+,16-,17-,18-,19-;;;/m11.../s1
InChIKey
MQZOUVOOWQRZHH-LYSWAWEJSA-J
Chemical Structure
2D Structure
2D structure of cyclohexane-1,2-diamine;oxalate;bis(4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoate);platinum(4+)
CAS: 2000236-36-0
CID: 176419014
Formula: C46H68N2O20Pt
MW: 1164.1
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight1164.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count22
Rotatable Bond Count12
Exact Mass1163.401337
Monoisotopic Mass1163.401337
Topological Polar Surface Area339 Ų
Heavy Atom Count69
Formal Charge0
Complexity1720
Isotope Atom Count0
Defined Atom Stereocenter Count16
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count5
Compound Is CanonicalizedYes